CerraCap Ventures

CerraCap Ventures is a Southern California-based venture capital firm specializing in early-stage technology investments. The firm focuses on enterprise (B2B) solutions in sectors such as cyber security, advanced analytics, and healthcare, aiming to empower high-growth innovative companies through its unique 'Sales & Scale' approach. This model leverages partnerships with Fortune 500 companies to drive growth and success. The firm's investment strategy targets seed, early-stage, and growth-stage companies, with investment sizes ranging from $1 million to $50 million. Geographically, CerraCap Ventures has a diverse focus, investing in regions including the United States, Mexico, Singapore, India, Israel, the United Kingdom, China, Japan, South Korea, Germany, France, Canada, Australia, Brazil, South Africa, Russia, Saudi Arabia, the United Arab Emirates, Argentina, and Chile. The industries of interest encompass cyber security, advanced analytics, healthcare, enterprise AI, quantum computing, fintech, edtech, agtech, clean tech, proptech, medtech, healthtech, biotech, robotics, and IoT. CerraCap Ventures has a track record of successful investments and exits. Notably, in July 2023, the firm celebrated a successful exit as ResMed acquired its portfolio company, Somnoware Healthcare Systems Inc., a leading web-based platform transforming respiratory healthcare. In November 2023, CerraCap Ventures participated in Entropica Labs' Series A funding round, reinforcing its dedication to making quantum computers useful. The firm's advisory board includes global leaders such as former President Vicente Fox of Mexico and John C. Cushman, Chairman of Cushman & Wakefield, reflecting its strong industry connections and commitment to fostering innovation.